Similarly, the percentage of cases that evolve to CF or to CFTR-RD and the age of evolution are variable in turn, and no markers are available so far to predict the cases of CRMS/CFSPID with a higher risk to evolve [12]. This evidence concerns the gene CFTR and cystic fibrosis.